top of page

Sutezolid with 3-drug combo appears safe and effective in multidrug-resistant TB

Adding the oxazolidinone antibiotic sutezolid to a three-drug combination appeared to be safe and effective for people with multidrug-resistant tuberculosis (TB), according to a dose-finding phase II study.Across five treatment arms that included four different doses of sutezolid with bedaquiline, delamanid, and moxifloxacin at standard doses, there was a similar increase in the Mycobacterium Growth Indicator Tube Time-to-Positivity (MGIT TTP) at 12 weeks, reported Norbert Heinrich, MD, a senior scientist at Ludwig Maximilian University Hospital in Munich, during the Conference on Retroviruses and Opportunistic Infections. Read more here.

57 views0 comments

Recent Posts

See All

John Green, the author of several books and a longtime supporter of Partners in Health, discusses his time visiting Sierra Leone’s Lakka Government Hospital, a tuberculosis treatment center. He talks

bottom of page